25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Igene Biotechnology Inc
Buy, Hold or Sell?

Let's analyze Igene together

I guess you are interested in Igene Biotechnology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Igene Biotechnology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Igene Biotechnology Inc

I send you an email if I find something interesting about Igene Biotechnology Inc.

1. Quick Overview

1.1. Quick analysis of Igene (30 sec.)










1.2. What can you expect buying and holding a share of Igene? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-165.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Igene (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.01
Total Value Per Share
$-0.01 - $0.00

2.2. Growth of Igene (5 min.)




Is Igene growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.7m-$2.6m-$64.7k-2.4%

How much money is Igene making?

Current yearPrevious yearGrowGrow %
Making money-$140.7k-$3.9m$3.8m2,735.5%
Net Profit Margin-3.6%-52.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Igene (5 min.)




2.4. Comparing to competitors in the Agricultural Inputs industry (5 min.)




  Industry Rankings (Agricultural Inputs)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Igene?

Welcome investor! Igene's management wants to use your money to grow the business. In return you get a share of Igene.

First you should know what it really means to hold a share of Igene. And how you can make/lose money.

Speculation

The Price per Share of Igene is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Igene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Igene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Igene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-89.9%0.00-89.9%0.00-2,549.5%0.00-1,081.2%0.00-1,263.6%
Usd Book Value Change Per Share0.00-41.3%0.00-41.3%0.017,462.6%0.001,451.6%0.00264.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-41.3%0.00-41.3%0.017,462.6%0.001,451.6%0.00264.6%
Usd Price Per Share0.01-0.01-0.01-0.02-0.05-
Price to Earnings Ratio-111.22--111.22--2.35--28.72--29.76-
Price-to-Total Gains Ratio-241.92--241.92-0.80--67.16--47.29-
Price to Book Ratio-5.71--5.71--3.51--3.63--9.99-
Price-to-Total Gains Ratio-241.92--241.92-0.80--67.16--47.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-413.3614,515.69
Gains per Year (10000000 shares)-1,653.4658,062.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1653-166305806358053
20-3307-33160116125116116
30-4960-49690174188174179
40-6614-66220232251232242
50-8267-82750290314290305
60-9921-99280348376348368
70-11574-115810406439406431
80-13228-132340464502464494
90-14881-148870522565522557
100-16535-165400580627580620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.01.00.0%0.08.02.00.0%0.09.02.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%3.08.00.027.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%3.08.00.027.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Igene Biotechnology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.007-101%0.001-103%0.000-116%
Book Value Per Share---0.002-0.0020%-0.002-2%-0.007+274%-0.007+272%
Current Ratio--2.3462.3460%1.739+35%1.124+109%1.426+65%
Debt To Asset Ratio--1.5761.5760%1.441+9%58.568-97%33.787-95%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%-0.003+2736%-0.001+1103%-0.001+1305%
Free Cash Flow Per Share--0.0000.0000%0.000-156%0.000-183%0.000+37%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-156%0.000-180%0.000-212%
Gross Profit Margin--3.7563.7560%1.183+217%1.422+164%1.111+238%
Intrinsic Value_10Y_max--0.006--------
Intrinsic Value_10Y_min---0.005--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min---0.001--------
Intrinsic Value_5Y_max--0.002--------
Intrinsic Value_5Y_min---0.002--------
Market Cap156540.006-9900%15654000.64015654000.6400%9392400.384+67%32560321.331-52%72478022.963-78%
Net Profit Margin---0.036-0.0360%-0.522+1368%-0.278+681%-1.114+3031%
Operating Margin---0.253-0.2530%-0.316+25%-0.110-57%-0.701+177%
Operating Ratio--0.9940.9940%1.286-23%0.650+53%1.167-15%
Pb Ratio-0.057+99%-5.708-5.7080%-3.507-39%-3.629-36%-9.990+75%
Pe Ratio-1.112+99%-111.221-111.2210%-2.353-98%-28.720-74%-29.760-73%
Price Per Share0.000-9900%0.0100.0100%0.006+67%0.021-52%0.046-78%
Price To Free Cash Flow Ratio-0.582+99%-58.231-58.2310%19.590-397%93958.806-100%46918.963-100%
Price To Total Gains Ratio-2.419+99%-241.918-241.9180%0.804-30189%-67.160-72%-47.286-80%
Quick Ratio--2.3182.3180%0.889+161%0.741+213%0.707+228%
Return On Assets---0.030-0.0300%-0.658+2125%-3.266+10945%-1.966+6548%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.0000.0000%0.007-101%0.001-103%0.000-116%
Usd Book Value---2742571.000-2742571.0000%-2677863.000-2%-10268610.200+274%-10195956.500+272%
Usd Book Value Change Per Share--0.0000.0000%0.007-101%0.001-103%0.000-116%
Usd Book Value Per Share---0.002-0.0020%-0.002-2%-0.007+274%-0.007+272%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%-0.003+2736%-0.001+1103%-0.001+1305%
Usd Free Cash Flow---268828.000-268828.0000%479444.000-156%322220.200-183%-368026.600+37%
Usd Free Cash Flow Per Share--0.0000.0000%0.000-156%0.000-183%0.000+37%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-156%0.000-180%0.000-212%
Usd Market Cap156540.006-9900%15654000.64015654000.6400%9392400.384+67%32560321.331-52%72478022.963-78%
Usd Price Per Share0.000-9900%0.0100.0100%0.006+67%0.021-52%0.046-78%
Usd Profit---140747.000-140747.0000%-3990937.000+2736%-1437306.000+921%-1850392.500+1215%
Usd Revenue--3957903.0003957903.0000%7644477.000-48%2777822.000+42%2272793.100+74%
Usd Total Gains Per Share--0.0000.0000%0.007-101%0.001-103%0.000-116%
 EOD+2 -6MRQTTM+0 -0YOY+16 -165Y+17 -1510Y+21 -11

3.3 Fundamental Score

Let's check the fundamental score of Igene Biotechnology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.112
Price to Book Ratio (EOD)Between0-1-0.057
Net Profit Margin (MRQ)Greater than0-0.036
Operating Margin (MRQ)Greater than0-0.253
Quick Ratio (MRQ)Greater than12.318
Current Ratio (MRQ)Greater than12.346
Debt to Asset Ratio (MRQ)Less than11.576
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.030
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Igene Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Igene Biotechnology Inc

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.

Fundamental data was last updated by Penke on 2024-11-04 07:57:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Igene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • A Net Profit Margin of -3.6% means that $-0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Igene Biotechnology Inc:

  • The MRQ is -3.6%. The company is making a loss. -1
  • The TTM is -3.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-3.6%0.0%
TTM-3.6%YOY-52.2%+48.7%
TTM-3.6%5Y-27.8%+24.2%
5Y-27.8%10Y-111.4%+83.6%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%3.2%-6.8%
TTM-3.6%2.8%-6.4%
YOY-52.2%5.3%-57.5%
5Y-27.8%5.2%-33.0%
10Y-111.4%4.8%-116.2%
4.3.1.2. Return on Assets

Shows how efficient Igene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • -3.0% Return on Assets means that Igene generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Igene Biotechnology Inc:

  • The MRQ is -3.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-3.0%0.0%
TTM-3.0%YOY-65.8%+62.8%
TTM-3.0%5Y-326.6%+323.7%
5Y-326.6%10Y-196.6%-130.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%0.9%-3.9%
TTM-3.0%0.8%-3.8%
YOY-65.8%1.6%-67.4%
5Y-326.6%1.3%-327.9%
10Y-196.6%1.2%-197.8%
4.3.1.3. Return on Equity

Shows how efficient Igene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • 0.0% Return on Equity means Igene generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Igene Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.7%-1.7%
TTM-1.4%-1.4%
YOY-2.9%-2.9%
5Y-2.6%-2.6%
10Y-2.5%-2.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Igene Biotechnology Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Igene is operating .

  • Measures how much profit Igene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • An Operating Margin of -25.3% means the company generated $-0.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Igene Biotechnology Inc:

  • The MRQ is -25.3%. The company is operating very inefficient. -2
  • The TTM is -25.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-25.3%TTM-25.3%0.0%
TTM-25.3%YOY-31.6%+6.3%
TTM-25.3%5Y-11.0%-14.3%
5Y-11.0%10Y-70.1%+59.1%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.3%6.8%-32.1%
TTM-25.3%4.7%-30.0%
YOY-31.6%7.3%-38.9%
5Y-11.0%7.2%-18.2%
10Y-70.1%5.5%-75.6%
4.3.2.2. Operating Ratio

Measures how efficient Igene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Igene Biotechnology Inc:

  • The MRQ is 0.994. The company is less efficient in keeping operating costs low.
  • The TTM is 0.994. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.994TTM0.9940.000
TTM0.994YOY1.286-0.292
TTM0.9945Y0.650+0.344
5Y0.65010Y1.167-0.517
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9941.517-0.523
TTM0.9941.352-0.358
YOY1.2861.289-0.003
5Y0.6501.379-0.729
10Y1.1671.233-0.066
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Igene Biotechnology Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Igene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A Current Ratio of 2.35 means the company has $2.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Igene Biotechnology Inc:

  • The MRQ is 2.346. The company is able to pay all its short-term debts. +1
  • The TTM is 2.346. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.346TTM2.3460.000
TTM2.346YOY1.739+0.607
TTM2.3465Y1.124+1.222
5Y1.12410Y1.426-0.302
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3461.507+0.839
TTM2.3461.573+0.773
YOY1.7391.651+0.088
5Y1.1241.717-0.593
10Y1.4261.615-0.189
4.4.3.2. Quick Ratio

Measures if Igene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • A Quick Ratio of 2.32 means the company can pay off $2.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Igene Biotechnology Inc:

  • The MRQ is 2.318. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.318. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.318TTM2.3180.000
TTM2.318YOY0.889+1.428
TTM2.3185Y0.741+1.577
5Y0.74110Y0.707+0.034
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3180.623+1.695
TTM2.3180.619+1.699
YOY0.8890.768+0.121
5Y0.7410.814-0.073
10Y0.7070.832-0.125
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Igene Biotechnology Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Igene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Igene to Agricultural Inputs industry mean.
  • A Debt to Asset Ratio of 1.58 means that Igene assets are financed with 157.6% credit (debt) and the remaining percentage (100% - 157.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Igene Biotechnology Inc:

  • The MRQ is 1.576. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.576. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.576TTM1.5760.000
TTM1.576YOY1.441+0.135
TTM1.5765Y58.568-56.991
5Y58.56810Y33.787+24.781
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5760.461+1.115
TTM1.5760.446+1.130
YOY1.4410.460+0.981
5Y58.5680.455+58.113
10Y33.7870.489+33.298
4.5.4.2. Debt to Equity Ratio

Measures if Igene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Igene to the Agricultural Inputs industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Igene Biotechnology Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.812-0.812
TTM-0.804-0.804
YOY-0.862-0.862
5Y-0.909-0.909
10Y-1.066-1.066
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Igene generates.

  • Above 15 is considered overpriced but always compare Igene to the Agricultural Inputs industry mean.
  • A PE ratio of -111.22 means the investor is paying $-111.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Igene Biotechnology Inc:

  • The EOD is -1.112. Based on the earnings, the company is expensive. -2
  • The MRQ is -111.221. Based on the earnings, the company is expensive. -2
  • The TTM is -111.221. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.112MRQ-111.221+110.109
MRQ-111.221TTM-111.2210.000
TTM-111.221YOY-2.353-108.867
TTM-111.2215Y-28.720-82.501
5Y-28.72010Y-29.760+1.040
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-1.11211.237-12.349
MRQ-111.22110.312-121.533
TTM-111.2219.989-121.210
YOY-2.35310.731-13.084
5Y-28.72013.246-41.966
10Y-29.76021.352-51.112
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Igene Biotechnology Inc:

  • The EOD is -0.582. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -58.231. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -58.231. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.582MRQ-58.231+57.648
MRQ-58.231TTM-58.2310.000
TTM-58.231YOY19.590-77.821
TTM-58.2315Y93,958.806-94,017.036
5Y93,958.80610Y46,918.963+47,039.843
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-0.5822.684-3.266
MRQ-58.2312.201-60.432
TTM-58.2311.760-59.991
YOY19.590-0.147+19.737
5Y93,958.8060.500+93,958.306
10Y46,918.9630.322+46,918.641
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Igene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A PB ratio of -5.71 means the investor is paying $-5.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Igene Biotechnology Inc:

  • The EOD is -0.057. Based on the equity, the company is expensive. -2
  • The MRQ is -5.708. Based on the equity, the company is expensive. -2
  • The TTM is -5.708. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.057MRQ-5.708+5.651
MRQ-5.708TTM-5.7080.000
TTM-5.708YOY-3.507-2.200
TTM-5.7085Y-3.629-2.079
5Y-3.62910Y-9.990+6.362
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0571.318-1.375
MRQ-5.7081.260-6.968
TTM-5.7081.331-7.039
YOY-3.5071.691-5.198
5Y-3.6291.910-5.539
10Y-9.9902.565-12.555
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2009-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,760
Total Liabilities7,502
Total Stockholder Equity-2,743
 As reported
Total Liabilities 7,502
Total Stockholder Equity+ -2,743
Total Assets = 4,760

Assets

Total Assets4,760
Total Current Assets3,660
Long-term Assets1,100
Total Current Assets
Cash And Cash Equivalents 1,295
Net Receivables 2,320
Other Current Assets 1
Total Current Assets  (as reported)3,660
Total Current Assets  (calculated)3,616
+/- 44
Long-term Assets
Property Plant Equipment 853
Intangible Assets 150
Long-term Assets Other 98
Long-term Assets  (as reported)1,100
Long-term Assets  (calculated)1,100
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,560
Long-term Liabilities5,942
Total Stockholder Equity-2,743
Total Current Liabilities
Short-term Debt 1,095
Short Long Term Debt 5
Accounts payable 465
Other Current Liabilities 465
Total Current Liabilities  (as reported)1,560
Total Current Liabilities  (calculated)2,031
+/- 471
Long-term Liabilities
Long term Debt 364
Other Liabilities 5,338
Long-term Liabilities  (as reported)5,942
Long-term Liabilities  (calculated)5,702
+/- 240
Total Stockholder Equity
Common Stock15,604
Retained Earnings -52,872
Accumulated Other Comprehensive Income 58
Other Stockholders Equity 34,467
Total Stockholder Equity (as reported)-2,743
Total Stockholder Equity (calculated)-2,743
+/-0
Other
Cash and Short Term Investments 1,295
Common Stock Shares Outstanding 1,537,790
Liabilities and Stockholders Equity 4,760
Net Debt 5,501
Net Tangible Assets -2,985
Net Working Capital 2,100
Preferred Stock Total Equity 4
Short Long Term Debt Total 6,796



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
> Total Assets 
1,817
2,014
3,539
3,209
12,427
496
231
75
13,099
6,066
4,760
4,7606,06613,0997523149612,4273,2093,5392,0141,817
   > Total Current Assets 
1,308
1,483
2,552
1,668
758
0
0
36
11,843
4,956
3,660
3,6604,95611,84336007581,6682,5521,4831,308
       Cash And Cash Equivalents 
216
144
394
498
63
204
120
22
1,026
1,488
1,295
1,2951,4881,0262212020463498394144216
       Net Receivables 
231
317
833
528
156
0
0
0
2,719
1,046
2,320
2,3201,0462,719000156528833317231
       Inventory 
708
762
960
375
44
0
0
0
8,060
2,399
0
02,3998,06000044375960762708
       Other Current Assets 
153
260
74
74
495
11
20
0
38
24
1
12438020114957474260153
   > Long-term Assets 
509
531
987
1,542
11,668
0
0
39
1,256
1,110
1,100
1,1001,1101,256390011,6681,542987531509
       Property Plant Equipment 
366
104
233
196
149
125
50
34
713
832
853
8538327133450125149196233104366
       Intangible Assets 
0
0
0
0
0
0
0
0
150
150
150
15015015000000000
       Long-term Assets Other 
142
427
754
1,345
11,519
0
0
5
393
128
98
9812839350011,5191,345754427142
> Total Liabilities 
8,702
9,819
14,522
17,013
16,347
14,600
15,375
16,493
27,459
8,744
7,502
7,5028,74427,45916,49315,37514,60016,34717,01314,5229,8198,702
   > Total Current Liabilities 
268
904
2,588
849
187
795
816
962
7,903
2,849
1,560
1,5602,8497,9039628167951878492,588904268
       Short-term Debt 
0
600
1,502
254
0
0
0
705
0
0
1,095
1,095007050002541,5026000
       Short Long Term Debt 
0
0
0
0
0
0
0
705
10,378
0
5
5010,3787050000000
       Accounts payable 
206
304
1,086
596
186
78
99
210
7,903
2,849
465
4652,8497,90321099781865961,086304206
       Other Current Liabilities 
62
135
62
0
1
12
12
47
0
0
465
46500471212106213562
   > Long-term Liabilities 
8,434
8,914
11,935
16,163
16,160
0
0
15,531
19,556
5,894
5,942
5,9425,89419,55615,5310016,16016,16311,9358,9148,434
       Other Liabilities 
0
1,337
1,927
3,357
3,398
4,149
4,903
5,656
11,442
5,307
5,338
5,3385,30711,4425,6564,9034,1493,3983,3571,9271,3370
> Total Stockholder Equity
-6,885
-7,805
-10,983
-13,803
-3,921
0
0
-16,419
-14,360
-2,678
-2,743
-2,743-2,678-14,360-16,41900-3,921-13,803-10,983-7,805-6,885
   Common Stock
476
622
758
929
927
1,017
1,075
1,093
1,103
15,185
15,604
15,60415,1851,1031,0931,0751,017927929758622476
   Retained Earnings -52,872-52,731-48,740-43,17200-39,320-37,121-33,931-30,258-28,002
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
20,239
21,412
22,189
22,388
34,471
0
0
25,660
33,277
34,886
34,467
34,46734,88633,27725,6600034,47122,38822,18921,41220,239



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2009-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,958
Cost of Revenue-2,942
Gross Profit1,0161,016
 
Operating Income (+$)
Gross Profit1,016
Operating Expense-991
Operating Income-1,07025
 
Operating Expense (+$)
Research Development1,851
Selling General Administrative838
Selling And Marketing Expenses388
Operating Expense9913,077
 
Net Interest Income (+$)
Interest Income0
Interest Expense-98
Other Finance Cost-98
Net Interest Income0
 
Pretax Income (+$)
Operating Income-1,070
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-43-2,097
EBIT - interestExpense = -1,100
25
-43
Interest Expense98
Earnings Before Interest and Taxes (EBIT)-1,00254
Earnings Before Interest and Taxes (EBITDA)-851
 
After tax Income (+$)
Income Before Tax-43
Tax Provision-0
Net Income From Continuing Ops-141-43
Net Income-141
Net Income Applicable To Common Shares-141
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,933
Total Other Income/Expenses Net1,0270
 

Technical Analysis of Igene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Igene. The general trend of Igene is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Igene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Igene Biotechnology Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Igene Biotechnology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Igene Biotechnology Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Igene Biotechnology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) ChartIgene Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Igene Biotechnology Inc. The current adx is .

Igene Biotechnology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Relative Strength Index (RSI) ChartIgene Biotechnology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Stochastic Oscillator ChartIgene Biotechnology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Commodity Channel Index (CCI) ChartIgene Biotechnology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Chande Momentum Oscillator (CMO) ChartIgene Biotechnology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Williams %R ChartIgene Biotechnology Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Average True Range (ATR) ChartIgene Biotechnology Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily On-Balance Volume (OBV) ChartIgene Biotechnology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Igene Biotechnology Inc.

Igene Biotechnology Inc Daily Money Flow Index (MFI) ChartIgene Biotechnology Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Igene Biotechnology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Igene Biotechnology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Igene Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Igene with someone you think should read this too:
  • Are you bullish or bearish on Igene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Igene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Igene Biotechnology Inc

I send you an email if I find something interesting about Igene Biotechnology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Igene Biotechnology Inc.

Receive notifications about Igene Biotechnology Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.